Metformin fails to reduce cardiovascular events in heart failure with reduced ejection fraction, trial shows

The Met-HeFT trial reveals that metformin does not significantly lower the risk of major cardiovascular events in patients with heart failure and reduced ejection fraction, challenging previous observational data suggesting potential benefits. Metformin does not appear to reduce the risk…













